{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-069218","form_type":"8-K","ticker":"NRIX","cik":"0001549595","company_name":"Nurix Therapeutics, Inc.","filed_at":"2023-03-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:45.528126+00:00","generated_at":"2026-06-18T04:25:20.592034+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Nurix Therapeutics discloses minimal SVB exposure; less than 1% of cash at SVB","bullets":["SVB closed by California DFPI on March 10; FDIC appointed receiver.","U.S. Treasury, Fed, FDIC: all depositors fully protected; funds accessible March 13.","Nurix's SVB account holds less than 1% of total cash, equivalents, and marketable securities.","Remaining cash held at other large, global financial institutions.","Company believes exposure is immaterial and funds will be fully available."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-069218","json":"https://secwatch.observer/filing/0001193125-23-069218.json","markdown":"https://secwatch.observer/filing/0001193125-23-069218.md","text":"https://secwatch.observer/filing/0001193125-23-069218.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1549595/000119312523069218/0001193125-23-069218-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1549595/000119312523069218/d484325d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-18T04:25:20.592034+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}